glp-1 drugs for inflammation Do reduce inflammation? The anti-inflammatory and immunological properties

3,5 In early T2DM managed with lifestyle alone, orforglipron lowered glycated hemoglobin A1c (HbA1c) by -1.24 to -1.48 percentage points over 40 weeks as compared to -0.41 with placebo, with no severe hypoglycemia reported and weight reduction ranging from 4.5% to 7.6%, 3 which led to mean HbA1c levels of 6.5-6.7%

The problem is paying for them, especially if your insurance provider denies coverage or you have no insurance at all

Common adverse reactions include nausea, vomiting, constipation, and diarrhea

This rapid expansion in use (with nearly 12% of Americans now having tried GLP-1 medications) has brought with it concerning reports of severe side effects that manufacturers allegedly failed to adequately disclose, forming the basis of thousands of lawsuits now consolidated in federal court

However, the limitation of tirzepatide is that it does not directly engage the glucagon receptor , which plays a crucial role in fat metabolism, hepatic energy expenditure, and thermogenesis